Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Tagrisso demonstrates superiority over chemotherapy in EGFR T790M mutation-positive non-small cell lung cancer
-
AstraZeneca completes agreement With Cilag GmbH International for rights to Rhinocort Aqua outside the US
-
AstraZeneca takes latest scientific advances in oncology to major US And European congresses
-
AstraZeneca head and neck cancer trials resume new patient enrolment as FDA lifts partial clinical hold
-
MedImmune completes out-licensing agreement with Allergan for MEDI2070
-
Year-to-date and Q3 2016 results
-
AstraZeneca head and neck cancer trials
-
Lynparza Phase III SOLO-2 trial shows significant progression-free survival benefit
-
FDA accepts for review New Drug Application for sodium zirconium cyclosilicate (ZS-9) for the treatment of hyperkalaemia
-
AstraZeneca enters agreement with Cilag GmbH International to divest rights to Rhinocort Aqua outside the US
Latest articles and press releases
All of our latest press releases and articles are available to explore
